Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus
- PMID: 15780448
- DOI: 10.1016/j.vaccine.2004.10.041
Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus
Abstract
The design of vaccines for RNA viral diseases is complicated by the high genetic variability of the viruses, which favors the selection of escape mutants. A case in point is foot-and-mouth disease virus (FMDV), for which only limited protection has been observed in vaccination with single peptides. We have explored the potential of immunogens of higher sequence diversity, covering a broad range of field or culture-induced mutations at the immunodominant site A of FMDV, serotype C. Four mixotope-type peptide libraries, containing ca. 3 x 10(3) or ca. 3 x 10(5) peptides each, in either linear or cyclic form, and combining most significant mutations found or induced at site A have been synthesized and used to immunize guinea-pigs. Substantial levels of serum conversion have been observed for all four mixotope libraries, as well as for single peptides, linear or cyclic, corresponding to the consensus site A sequence. The specificity and neutralizing ability of the anti-mixotope and -peptide antibodies have been evaluated by direct ELISA and by plaque reduction and micro-neutralization assays, respectively. Challenge experiments with an infectious, guinea-pig-adapted FMDV strain, have shown higher protection rates in animals immunized with the cyclic versions, either in single sequence or in combinatorial mixotope form.
Similar articles
-
A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide.Vet Microbiol. 2007 Dec 15;125(3-4):224-31. doi: 10.1016/j.vetmic.2007.05.033. Epub 2007 Jun 16. Vet Microbiol. 2007. PMID: 17656048
-
Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.Vet Microbiol. 2007 Mar 10;120(3-4):193-206. doi: 10.1016/j.vetmic.2006.10.029. Epub 2006 Oct 28. Vet Microbiol. 2007. PMID: 17127019
-
Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.J Immunol Methods. 2007 Apr 10;321(1-2):142-51. doi: 10.1016/j.jim.2007.01.014. Epub 2007 Feb 14. J Immunol Methods. 2007. PMID: 17328909
-
Selection of foot and mouth disease vaccine strains--a review.Rev Sci Tech. 2005 Dec;24(3):981-93. Rev Sci Tech. 2005. PMID: 16642769 Review.
-
Control of foot-and-mouth disease by vaccination.Dev Biol Stand. 1999;100:131-5. Dev Biol Stand. 1999. PMID: 10616183 Review. No abstract available.
Cited by
-
Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.Hum Vaccin Immunother. 2016 Oct 2;12(10):2640-2648. doi: 10.1080/21645515.2016.1191718. Epub 2016 Jun 13. Hum Vaccin Immunother. 2016. PMID: 27295540 Free PMC article. Review.
-
Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive.Transgenic Res. 2008 Dec;17(6):1163-70. doi: 10.1007/s11248-008-9188-1. Epub 2008 Jul 24. Transgenic Res. 2008. PMID: 18651235
-
Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.Vaccines (Basel). 2021 May 8;9(5):477. doi: 10.3390/vaccines9050477. Vaccines (Basel). 2021. PMID: 34066901 Free PMC article. Review.
-
Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.BMC Biotechnol. 2007 Sep 27;7:62. doi: 10.1186/1472-6750-7-62. BMC Biotechnol. 2007. PMID: 17900346 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources